申请人:Treventis Corporation
公开号:US20150217004A1
公开(公告)日:2015-08-06
In general, among other things, compounds of Formula I are provided:
or a pharmaceutically acceptable salt thereof, in which R
1-7, 9-10
are each independently selected from the group consisting of hydrogen, hydroxy, alkoxy, and alkyl; and R
8
is selected from the group consisting of fluoro, iodo, and tributyltin. Other compounds are also provided. Methods of treatment and diagnosis are also provided.
一般而言,本发明提供了公式I的化合物:或其药学上可接受的盐,其中R1-7、9-10各自独立地选自氢、羟基、烷氧基和烷基的群组,而R8选自氟、碘和三丁基锡的群组。本发明还提供了其他化合物。本发明还提供了治疗和诊断方法。